Evidence map›Paper›PMID 36276950›Full record

ArticleFrontiers in genetics2022

A pathogenic variant of TULP3 causes renal and hepatic fibrocystic disease.

Hossein Jafari Khamirani, Vivek Reddy Palicharla, Seyed Alireza Dastgheib, Mehdi Dianatpour, Mohammad Hadi Imanieh, Seyed Sajjad Tabei, Whitney Besse, Saikat Mukhopadhyay, Karel F Liem

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Hossein Jafari KhamiraniDepartment of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.
Vivek Reddy PalicharlaDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Seyed Alireza DastgheibDepartment of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.
Mehdi DianatpourDepartment of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad Hadi ImaniehGastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyed Sajjad TabeiShiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Whitney BesseDepartment of Internal Medicine, Section of Nephrology, Yale School of Medicine, New Haven, CT, United States.
Saikat MukhopadhyayDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Karel F LiemVertebrate Developmental Biology Program, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, United States.
Shiraz University of Medical Sciences · IRThe University of Texas Southwestern Medical Center · USYale University · US

Funding

Tubulin Beta 4a in central nervous system development and diseaseR01NS097928 · NINDS · YALE UNIVERSITY · PI LIEM, KAREL F · 2016 to 2020
$2.5M
Role of primary cilium-generated signaling in polycystic kidney diseaseR01DK128089 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI MUKHOPADHYAY, SAIKAT · 2022 to 2025
$2.4M
NIDDK NIH HHS R01 DK128089NINDS NIH HHS R01 NS097928
6 · The paper itself

Abstract

Patient variants in

Indexed as

ciliaciliopathycystfibrosiskidneyliverPKDtubby domain

Identifiers

PMID36276950
PMCPMC9585244
OpenAlexW4303044639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.